Dr. Hongwei Li 李红卫
Chief Physician
Department of Radiation Oncology, Shanxi Cancer Hospital, Taiyuan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of head and neck tumors, esophageal cancer, and lung cancer.
Dr. Li is Chief Physician and Director of the Sixth Radiotherapy Ward at Shanxi Cancer Hospital. From 2002 to 2003, Dr. Li studied at the McGill University Cancer Centre in Canada with provincial funding. Dr. Li has published over 20 articles in domestic and international oncology journals and received a Second Prize for Scientific and Technological Progress in Shanxi Province.
Professional roles
- Member, Radiotherapy Association of Shanxi Branch, Chinese Medical Association
- Member, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Li Hongwei). Papers usually list the name as Hongwei Li or Li H.
Selected publications
28 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2024 (senior author): Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma. PubMed 39834937
- Front Oncol, 2021 (first author): Best Supportive Care Versus Whole-Brain Irradiation, Chemotherapy Alone, or WBRT Plus Chemotherapy in Patients With Brain Metastases From Small-Cell Lung Cancer: A Case-Controlled Analysis. PubMed 33732638
- Cancer Manag Res, 2020 (first author): The Clinical Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Brain Metastases from Non-Small Cell Lung Cancer-Harboring EGFR Mutations. PubMed 32765069
- Genes Immun, 2019 (first author): Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations. PubMed 30410015
- Oncol Lett, 2018 (senior author): A study of the application of fiberoptic bronchoscopy combined with liquid-based cytology test in the early diagnosis of lung cancer. PubMed 30344732
- Oncotarget, 2017 (first author): Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases. PubMed 29050314
- Thorac Cancer, 2017 (first author): Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status. PubMed 28597503
- J Neurooncol, 2017 (first author): Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations. PubMed 28391386
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion